PrEP Access and Future Horizons: Changes in the Drug Market and Coverage


The HIV pre-exposure prophylaxis (PrEP) landscape is rapidly changing. With the introduction of new drugs approved for PrEP and generic options becoming available, many changes are underway or on the horizon. In this webinar, NASTAD discusses the many changes underwayincluding:

  • The introduction of generic TDF/FTC to the US market
  • Covering PrEP as an Essential Health Benefit
  • Expected changes in PrEP coverage